Investor Relations –

SEC Filing Details

Overview Financial Information

Document Details

Form

Filing Date

Jul 28, 2026

Document Date

Jun 15, 2026

Form Description

Initial filing by director officer or owner of more than ten percent

Filing Group

3,4,5

Company

Faeth Therapeutics, Inc.

Issuer

FAETH THERAPEUTICS, INC.

Filer

Khosla Ventures VI, L.P.

Filing Formats

View HTML

Download PDF

Download DOC

Download XLS

The drug product candidates described on this website are investigational agents that have not been approved by the Food and Drug Administration or any other regulatory authority. Their safety and efficacy have not been established.